Loading clinical trials...
Loading clinical trials...
Application of Megavoltage Imaging to Reduce Artifact Following Interstitial Seed Implants for Prostate Adenocarcinoma
This is a non-randomized study to evaluate the utility of MVCT as a quality assurance measure in patients treated with interstitial permanent seed implants for low and intermediate risk prostate cancer. All patients will received the same standard of care treatment but will receive an additinoal CT image of the prostate.
Age
50 - 80 years
Sex
MALE
Healthy Volunteers
No
Markey Cancer Center
Lexington, Kentucky, United States
Start Date
September 1, 2013
Primary Completion Date
April 1, 2016
Completion Date
April 1, 2016
Last Updated
September 26, 2017
10
ACTUAL participants
MVCT
RADIATION
Lead Sponsor
William St Clair
NCT06842498
NCT04550494
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05691465